Katleen Vereecken - Search Results

Year	Number of Results
2002	1
2005	1
2006	1
2007	1
2008	3
2009	1
2011	2
2012	2
2013	3
2016	1
2018	1
2021	1
2022	2
2023	1
2024	0

1

Chikungunya Virus' High Genomic Plasticity Enables Rapid Adaptation to Restrictive A549 Cells.

De Caluwé L, Heyndrickx L, Coppens S, Vereecken K, Quiñones-Mateu ME, Merits A, Ariën KK, Bartholomeeusen K. De Caluwé L, et al. Among authors: vereecken k. Viruses. 2022 Jan 28;14(2):282. doi: 10.3390/v14020282. Viruses. 2022. PMID: 35215875 Free PMC article.

2

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.

Ariën KK, Heyndrickx L, Michiels J, Vereecken K, Van Lent K, Coppens S, Willems B, Pannus P, Martens GA, Van Esbroeck M, Goossens ME, Marchant A, Bartholomeeusen K, Desombere I. Ariën KK, et al. Among authors: vereecken k. NPJ Vaccines. 2022 Mar 8;7(1):35. doi: 10.1038/s41541-022-00459-z. NPJ Vaccines. 2022. PMID: 35260578 Free PMC article.

3

The CD147 Protein Complex Is Involved in Entry of Chikungunya Virus and Related Alphaviruses in Human Cells.

De Caluwé L, Coppens S, Vereecken K, Daled S, Dhaenens M, Van Ostade X, Deforce D, Ariën KK, Bartholomeeusen K. De Caluwé L, et al. Among authors: vereecken k. Front Microbiol. 2021 Feb 25;12:615165. doi: 10.3389/fmicb.2021.615165. eCollection 2021. Front Microbiol. 2021. PMID: 33717005 Free PMC article.

4

Genome Mining Uncovers NRPS and PKS Clusters in Rothia dentocariosa with Inhibitory Activity against Neisseria Species.

Akomoneh EA, Gestels Z, Abdellati S, Vereecken K, Bartholomeeusen K, Van den Bossche D, Kenyon C, Manoharan-Basil SS. Akomoneh EA, et al. Among authors: vereecken k. Antibiotics (Basel). 2023 Nov 4;12(11):1592. doi: 10.3390/antibiotics12111592. Antibiotics (Basel). 2023. PMID: 37998794 Free PMC article.

5

A Chikungunya Virus trans-Replicase System Reveals the Importance of Delayed Nonstructural Polyprotein Processing for Efficient Replication Complex Formation in Mosquito Cells.

Bartholomeeusen K, Utt A, Coppens S, Rausalu K, Vereecken K, Ariën KK, Merits A. Bartholomeeusen K, et al. Among authors: vereecken k. J Virol. 2018 Jun 29;92(14):e00152-18. doi: 10.1128/JVI.00152-18. Print 2018 Jul 15. J Virol. 2018. PMID: 29695432 Free PMC article.

6

Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination model.

Heyndrickx L, Stewart-Jones G, Jansson M, Schuitemaker H, Bowles E, Buonaguro L, Grevstad B, Vinner L, Vereecken K, Parker J, Ramaswamy M, Biswas P, Vanham G, Scarlatti G, Fomsgaard A; NGIN Consortium. Heyndrickx L, et al. Among authors: vereecken k. PLoS One. 2013 Sep 2;8(9):e74552. doi: 10.1371/journal.pone.0074552. eCollection 2013. PLoS One. 2013. PMID: 24023951 Free PMC article.

7

Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays.

Heyndrickx L, Vermoesen T, Vereecken K, Kurth J, Coppens S, Aerts L, Ohagen A, Van Herrewege Y, Lewi P, Vanham G. Heyndrickx L, et al. Among authors: vereecken k. J Virol Methods. 2008 Mar;148(1-2):166-73. doi: 10.1016/j.jviromet.2007.11.009. Epub 2008 Jan 14. J Virol Methods. 2008. PMID: 18192031

8

MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.

Grupping K, Selhorst P, Michiels J, Vereecken K, Heyndrickx L, Kessler P, Vanham G, Martin L, Ariën KK. Grupping K, et al. Among authors: vereecken k. Retrovirology. 2012 May 2;9:36. doi: 10.1186/1742-4690-9-36. Retrovirology. 2012. PMID: 22551420 Free PMC article.

9

Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes.

Beels D, Heyndrickx L, Vereecken K, Vermoesen T, Michiels L, Vanham G, Kestens L. Beels D, et al. Among authors: vereecken k. J Virol Methods. 2008 Jan;147(1):99-107. doi: 10.1016/j.jviromet.2007.08.014. Epub 2007 Sep 29. J Virol Methods. 2008. PMID: 17904649

10

Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.

Selhorst P, Vazquez AC, Terrazas-Aranda K, Michiels J, Vereecken K, Heyndrickx L, Weber J, Quiñones-Mateu ME, Ariën KK, Vanham G. Selhorst P, et al. Among authors: vereecken k. Antimicrob Agents Chemother. 2011 Apr;55(4):1403-13. doi: 10.1128/AAC.01426-10. Epub 2011 Jan 31. Antimicrob Agents Chemother. 2011. PMID: 21282453 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year